story of the week
9p21 Loss Confers Primary Resistance to Immune Checkpoint Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Nat Commun 2021 Sep 23;[EPub Ahead of Print], G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, O Alhalabi, R Wang, M Dang, E Dai, S Zhang, F Nie, S Zhao, C Guo, A Hamza, B Czerniak, C Cheng, A Siefker-Radtke, K Bhat, A Futreal, G Peng, J Wargo, W Peng, H Kadara, J Ajani, C Swanton, K Litchfield, JR Ahnert, J Gao, L WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.